Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KLK7 | P49862 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9065289 | 0.83 | ALDH1A1 (0.46) | ALDH1A1LMNAMAPTMAPK1CES2 | |
| SCHEMBL29176812 | 0.81 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTMAPK1CES2 | |
| SCHEMBL27521149 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTMAPK1PRKCA | |
| SCHEMBL120571 | 0.76 | LMNA (0.40) | ALDH1A1LMNAMAPTMAPK1PRKCA | |
| SCHEMBL8947471 | 0.75 | MAPT (0.51) | ALDH1A1LMNAMAPTMAPK1PRKCA | |
| SCHEMBL15635118 | 0.75 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1CES2 | |
| SCHEMBL5930621 | 0.75 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1CES2 | |
| SCHEMBL2719944 | 0.75 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTMAPK1CES2 | |
| SCHEMBL17866535 | 0.75 | — | — | |
| SCHEMBL8830888 | 0.74 | LMNA (0.48) | ALDH1A1LMNAMAPTMAPK1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9346845-B2 | Anionic conjugates of glycosylated bacterial metabolite | GLYCAN BIOSCIENCES LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-9339781-B2 | Polymer particles | THE UNIVERSITY OF SYDNEY (AU) | 2016-05-17 | — | — | US | disclosed |
| US-8993697-B2 | Conducting and semiconducting organic materials | Commonwealth Scientific and Industrial Research Institute Organisation (AU) | 2015-03-31 | — | — | US | disclosed |
| US-20140329932-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2014-11-06 | — | — | US | disclosed |
| US-20140323422-A1 | Anionic Conjugates of Glycosylated Bacterial Metabolite | Glycosynnovations Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| US-20130289217-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-10-31 | — | — | US | disclosed |
| US-8501889-B2 | Conducting and semiconducting organic materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-06 | — | — | US | disclosed |
| EP-2421877-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | Glycan Biosciences Pty Ltd (AU) | 2012-02-29 | — | — | EP | disclosed |
| EP-2401304-A1 | POLYMER PARTICLES | The University Of Sydney (AU) | 2012-01-04 | — | — | EP | disclosed |
| US-20110190233-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2011-08-04 | — | — | US | disclosed |
| US-20110166298-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL ORGANISATION (AU) | 2011-07-07 | — | — | US | disclosed |
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | THE UNIVERSITY OF QUEENSLAND | 2010-05-27 | — | — | US | disclosed |
| US-5661153-A | FOR TREATING ALLERGIES, ASTHMA, DERMATITIS, GRAFT REJECTIONS | JAPAN ENERGY CORPORATION (JP) | 1997-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190233-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GNE, CD44, FUT5 | ALDH1A1 1240/4885LMNA 3251/4885MAPT 3081/4885 |
| US-20140323422-A1 | Anionic Conjugates of Glycosylated Bacterial Metabolite | GNE, CD44, FUT5 | ALDH1A1 1240/4885LMNA 3251/4885MAPT 3081/4885 |
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | OPRL1, CRH, OPRK1 | ALDH1A1 2824/4885LMNA 2762/4885MAPT 2785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.